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Abstract. 
 
A caspase 8–deﬁcient subline (JB6) of hu-
man Jurkat cells can be killed by the oligomerization of
Fas-associated protein with death domain (FADD).
This cell death process is not accompanied by caspase
activation, but by necrotic morphological changes.
Here, we show that the death effector domain of
FADD is responsible for the FADD-mediated necrotic
pathway. This process was accompanied by a loss of mi-
 
tochondrial transmembrane potential (
 
DC
 
m), but not
by the release of cytochrome c from mitochondria. Pyr-
rolidine dithiocarbamate, a metal chelator and antioxi-
dant, efﬁciently inhibited the FADD-induced reduction
of 
 
DC
 
m and necrotic cell death. When human Jurkat,
or its transformants, expressing mouse Fas were treated
with Fas ligand or anti–mouse Fas antibodies, the cells
died, showing characteristics of apoptosis. A broad
caspase inhibitor (z-VAD–fmk) blocked the apoptotic
morphological changes and the release of cytochrome
c. However, the cells still died, and this cell death pro-
cess was accompanied by a strong reduction in 
 
DC
 
m, as
well as necrotic morphological changes. The presence
of z-VAD–fmk and pyrrolidine dithiocarbamate to-
gether blocked cell death, suggesting that both apop-
totic and necrotic pathways can be activated through
the Fas death receptor.
Key words: apoptosis • caspase • Fas • mitochondrial
membrane potential • necrosis
 
Introduction
 
Based on morphological changes, cell death in mammals is
classified into two types: apoptosis and necrosis (Wyllie et
al., 1980; Duval and Wyllie, 1986). Apoptosis is character-
ized by plasma membrane blebbing, condensation, and
fragmentation of cells and nuclei, as well as extensive deg-
radation of chromosomal DNA into nucleosomal units
(Wyllie, 1980). On the other hand, necrosis is accompa-
nied by the swelling of cells and organelles, in addition to
the ultimate disintegration of the plasma membrane.
Apoptosis can be triggered by a variety of stimuli, in-
cluding genotoxic agents, factor deprivation, and death
factors (Nagata, 1997; Ashkenazi and Dixit, 1998; Green
and Reed, 1998; Raff, 1998). It is involved in the removal
of surplus cells generated during mammalian develop-
ment, and in the removal of virally infected or cancer
cells as part of the immune response (Raff et al., 1993;
Nagata, 1997). Apoptotic signal transduction has been
extensively studied biochemically and genetically, and it
is now known that a family of cysteine proteases with as-
partate specificity are the major effectors of the process
(Thornberry and Lazebnik, 1998). Caspases exist as inac-
tive precursors in proliferating cells and are activated in a
cascade. Upon exposure to apoptotic stimuli, initiator
caspases are activated by the formation of a complex
with other molecules. Once the initiator caspases are
activated, they cause the processing of downstream cas-
pases, which cleave a set of cellular proteins, leading to
morphological changes and the degradation of chromo-
somal DNA. Necrosis is known to occur as a result of
complement attack, severe hypoxia, hyperthermia, lytic
viral infection, or exposure to a variety of toxins and res-
 
piratory poisons. Tumor necrosis factor (TNF)
 
1
 
 can acti-
vate the necrotic death program in some cell lines, such
as mouse L929 cells (Vercammen et al., 1998a). An in-
volvement of necrosis in the removal of interdigital cells
in the mouse embryo has also been suggested (Chautan
 
Address correspondence to Shigekazu Nagata, Osaka University Medical
School, B-3, Department of Genetics, 2-2 Yamada-oka, Suita, Osaka 565-
0871, Japan. Tel.: 81-6-68-79-33-10. Fax: 81-6-68-79-33-19. E-mail: nagata
@genetic.med.osaka-u.ac.jp
A. Kawahara’s present address is Laboratory of Molecular Genetics,
National Institute of Child Health and Human Development, Building
6B, Room 420, NIH, Bethesda, MD 20892.
 
1
 
Abbreviations used in this paper:
 
 BHA, butylated hydroxyanisole;
DD, death domain; DED, death effector domain; FADD, Fas-associ-
ated protein with death domain; FasL, Fas ligand; FKBP, FK506-bind-
ing protein; LZ-FasL, FasL tagged with a leucine-zipper motif; PDTC,
pyrrolidine dithiocarbamate; TNF, tumor necrosis factor; z-VAD–fmk,
 
carbobenzoyl-Val-Ala-Asp-fluoromethylketone; 
 
DC
 
m, mitochondrial
transmembrane potential. 
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et al., 1999). In contrast to apoptotic cell death, the mo-
lecular mechanism of necrosis is not well understood,
though several mechanisms, including the release of lyso-
somal enzymes, the generation of toxic oxygen radicals,
and the activation of calcium-dependent phospholipases,
have been proposed (Fiers et al., 1999).
Fas ligand (FasL) is a member of the TNF family (Na-
gata and Golstein, 1995; Nagata, 1997) and was originally
identified as a cytokine that triggers apoptosis by binding
to Fas (Suda et al., 1993). Studies on FasL-induced apop-
tosis have revealed the following mechanism. The bind-
ing of FasL or agonistic anti-Fas antibody to Fas rapidly
recruits procaspase 8 through an adaptor called FADD
(Fas-associated protein with death domain) (Boldin et
al., 1995; Chinnaiyan et al., 1995). FADD carries a do-
main called a death domain (DD) at its COOH terminus,
which is involved in the binding to Fas. The NH
 
2
 
-termi-
nal part of FADD is called the death effector domain
(DED) and is responsible for recruiting procaspase 8
(Boldin et al., 1996; Muzio et al., 1996). Thus, procaspase
8 oligomerized at the plasma membrane is autoactivated
to a mature enzyme (Muzio et al., 1998; Yang et al.,
1998). Two pathways have been shown for the signal
transduction downstream of caspase 8, which are used in
different cell types (types I and II) (Scaffidi et al., 1998).
In type I cells, caspase 8 directly activates procaspase 3.
However, in type II cells, caspase 8 cleaves Bid, a proap-
optotic member of the Bcl-2 family (Li et al., 1998; Luo
et al., 1998; Gross et al., 1999). The cleaved Bid translo-
cates to the mitochondria and stimulates the release of
cytochrome c. Cytochrome c, together with Apaf-1, acti-
vates procaspase 9 (Li et al., 1997), which leads to the
downstream processing of procaspase 3.
We and others have recently established sublines
from human Jurkat cells that do not express caspase 8
(Juo et al., 1998; Kawahara et al., 1998). Engagement of
Fas by agonistic anti–human Fas antibodies in these cell
lines does not activate caspases, and, thus, cannot in-
duce apoptotic cell death. On the other hand, when
FADD was artificially oligomerized, these cells died.
This cell death process was not accompanied by either
activation of the caspase cascade or apoptotic morpho-
logical cell changes. Rather, the cells showed a necrotic
morphology, suggesting that FADD can mediate not
only caspase-dependent apoptotic signals, but also
caspase-independent necrotic death signals.
To examine the necrotic death-signaling pathway, we
prepared various mutants of FADD and showed that
FADD’s DED domain is responsible for transducing
the signal. This death process was accompanied by a
loss of mitochondrial membrane potential, but not by
the release of cytochrome c from mitochondria, and was
inhibited by pyrrolidine dithiocarbamate (PDTC). We
then showed that Fas engaged by FasL or anti-Fas anti-
bodies could activate both caspase-dependent and -in-
dependent cell death signals. The caspase-dependent
signal was rapid and was accompanied by the release of
cytochrome c from mitochondria, as well as apoptotic
morphological changes. In contrast, the caspase-inde-
pendent cell death occurred slowly and was accompa-
nied by the loss of mitochondrial membrane potential
and necrotic morphological changes.
 
Materials and Methods
 
Cell Lines and Materials
 
Jurkat, a human T cell lymphoma cell line, and its derivative, JB6, which is
deficient in caspase 8 (Kawahara et al., 1998), were maintained in RPMI
1640 medium containing 10% FCS (EQUITECH-BIO, Inc.). AP1510,
a dimerizer of FK506-binding protein (FKBP) (Amara et al., 1997),
was provided by Dr. M. Gilman (ARIAD Pharmaceuticals, Inc., Cam-
bridge, MA). PDTC and carbobenzoyl-Val-Ala-Asp-fluoromethylketone
(z-VAD–fmk) were purchased from Sigma-Aldrich and Takara Shuzo,
Co., respectively. Monoclonal antibodies against human caspase 3 and
FADD were purchased from Transduction Laboratories. The monoclonal
antibodies against human cytochrome c, human cytochrome oxidase sub-
unit II, and the FLAG epitope were from BD PharMingen, Molecular
Probes, and Sigma-Aldrich, respectively. Horseradish peroxidase–conju-
gated anti–mouse IgG used as a secondary antibody was obtained from Dako.
The recombinant human FasL tagged with a leucine-zipper motif (LZ-
FasL) (Walczak et al., 1999) was produced by transfecting COS cells with
the FasL-expression plasmid. The concentration of FasL in the superna-
tant of the transfected COS cells was determined by ELISA using anti–
human FasL antibodies, as described previously (Tanaka et al., 1996).
 
Establishment of Stable Transformants
 
The plasmid pEF-FK-FADD carries the coding sequence (FKBP-FADD)
for a myristilation-targeting peptide, two tandem repeats of FKBP12, and
human FADD in the pEF-BOS mammalian expression vector (Kawahara
et al., 1998). The DNA fragments coding for the DED of FADD (FADD-
DED, amino acids 1–117), its truncated form (FADD-
 
D
 
DED, amino acids
79–117), and the DD of FADD (FADD-DD, amino acids 105–208) were
prepared from human FADD cDNA (Boldin et al., 1995; Chinnaiyan et
al., 1995). They were fused to a DNA fragment carrying a myristilation-
targeting peptide and two tandem repeats of FKBP12, and inserted into
pEF-BOS to generate pEF-FK-DED, pEF-F-FK-DED, pEF-F-FK-
 
D
 
DED, and pEF-FK-DD (Fig. 1 A). In pEF-F-FK-DED and pEF-F-FK-
 
D
 
DED, a DNA fragment coding for the FLAG epitope (DYKDDDDK)
was inserted between the myristilation-targeting peptide and FKBP.
The stable cell transformants expressing FADD-DD, FADD-DED,
and FADD-
 
D
 
DED were established, as previously described (Kawahara
et al., 1998). In brief, cells were cotransfected with 50 
 
m
 
g of the respective
expression vectors with 1 
 
m
 
g of the hygromycin-resistant gene (pMiwhyg)
by electroporation. Cells were cultured in the presence of 0.8–1.0 mg/ml of
hygromycin, and the transformant clones expressing FADD-DD, FADD-
DED, or FADD-
 
D
 
DED were identified by Western blotting using anti-
FADD or anti-FLAG antibodies. Jurkat cell transformants expressing
high levels of mouse Fas were established by introducing the mouse Fas
expression plasmid (Watanabe-Fukunaga et al., 1992).
 
Cell Viability Assay and FACS
 
®
 
 Analysis
 
Cell viability was determined by the WST-1 assay, as described previously
(Kawahara et al., 1998). In brief, Jurkat and JB6 cell transformants (5 
 
3
 
10
 
4
 
 cells in 100 
 
m
 
l) expressing the chimeric proteins, which were made
from FADD and FKBP, were treated at 37
 
8
 
C with AP1510. Human Jur-
kat and its transformant expressing mouse Fas (JmF) were treated with 50
ng/ml LZ-FasL and 1 
 
m
 
g/ml of the Jo2 antibody (Ogasawara et al., 1993),
respectively. WST-1 reagents, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium monosodium salt (Dojin Laboratories)
and 1-methoxy-5-methylphenazinium methylsulfate (Dojin Laboratories),
were added to the cells at final concentrations of 5.0 and 0.2 mM, respec-
tively, and incubated for 1 h at 37
 
8
 
C. Using an ELISA autoreader, the cell
viability was determined by measuring the difference between the absor-
bance at 450 and 620 nm. To examine the effect of various metabolic
inhibitors on the cell death, cells were preincubated for 1 h with PDTC,
z-VAD–fmk, or both.
The 
 
DC
 
m and the formation of oxygen radicals were determined by
staining cells with the Mitotracker orange reagents, CMTMRos, and CM-
H
 
2
 
TMRos (Molecular Probes), respectively, as described previously
(Bossy-Wetzel et al., 1998). In brief, cells (10
 
6
 
 cells/ml or otherwise stated)
were incubated at 37
 
8
 
C for 30 min with 25 nM CMTMRos or 100 nM CM-
H
 
2
 
TMRos in RPMI1640 containing 10% FCS. Cells were washed with
PBS and analyzed on a FACS
 
®
 
Calibur flow cytometer (Becton Dickin-
son) with excitation at 488 nm, using an argon laser. The fluorescence
from CMTMRos was detected with a 585/42 nm band pass filter. 
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Subcellular Fractionation and Western Blotting
 
The subcellular fractions were prepared essentially according to Gross et
al. (1999). In brief, 2 
 
3
 
 10
 
7
 
 cells were washed with PBS, suspended in 150
 
m
 
l ice-cold isotonic homogenizing buffer (buffer A, 200 mM mannitol, 70
mM sucrose, 1 mM EGTA, 10 mM Hepes-KOH, pH 7.4, 0.1 mM
 
p
 
APMSF), and homogenized in a glass Dounce homogenizer (Wheaton)
with a tight pestle (10 strokes). Unlysed cells and nuclei were removed by
centrifugation at 120 
 
g
 
 for 5 min. The supernatant was spun at 10,000 
 
g
 
 for
10 min, and the pellet, which was resuspended in buffer A, was used as the
heavy membrane fraction containing mitochondria. The supernatant was
further spun at 100,000 
 
g
 
 for 30 min, and the resultant supernatant was
used as the S100 fraction.
For Western blotting analysis, samples were mixed with an equal vol-
ume of 2
 
3 
 
Laemmli’s sample buffer. After heating at 95
 
8
 
C for 10 min,
proteins were separated by electrophoresis in a 15–25% gradient poly-
acrylamide gel (Dai-ichi Chemical), and then they were transferred to a
polyvinylidene difluoride membrane (Hybond P; Amersham-Pharmacia
 
Biotech). The membrane was blocked with PBST (PBS supplemented
with 0.05% Tween 20) containing 5% nonfat dry milk, followed by succes-
sive incubations with primary and secondary antibodies. Proteins were vi-
sualized with the enhanced chemiluminescence system (Renaissance;
NEN Life Science Products Inc.).
 
Results
 
Requirement of DED for Necrotic Death Induced by 
FADD Oligomerization
 
Artificial oligomerization of FADD can kill JB6 cells; this
death is accompanied by necrotic morphological changes
and occurs in a caspase-independent manner (Kawahara
et al., 1998). FADD contains two distinct domains, the DD
and DED (Boldin et al., 1995; Chinnaiyan et al., 1995), of
which DED mediates the apoptotic cell death by recruit-
ing caspase 8. To examine which domain is responsible for
the caspase-independent cell death process, FADD-DD or
FADD-DED was joined to two copies of FKBP, and the
resulting expression plasmids were introduced into Jurkat
or JB6 cells (Fig. 1 A). When the transformants were
treated for 6 h with AP1510 to oligomerize the chimeric
proteins, Jurkat cell transformants expressing FKBP-
DED, but not FKBP-DD, were killed in a dose-dependent
manner (Fig. 1 B). Oligomerization of FKBP-DED, but
not FKBP-DD, also efficiently killed the JB6 cells. When
the DED was truncated, its death-inducing activity was de-
stroyed. As found with FKBP-FADD (Kawahara et al.,
1998), the FKBP-induced death of Jurkat cells was accom-
panied by caspase activation and apoptotic morphological
changes. In contrast, the oligomerization of FKBP-DED
in JB6 cells did not activate caspases, though it did induced
necrotic morphological changes (data not shown). These
results indicate that the FADD-DED is responsible for
transducing not only the caspase-mediated apoptotic sig-
nal, but also the caspase-independent death signal.
 
Inhibitory Effect of PDTC on Caspase-independent
Cell Death
 
To study the molecular mechanism of the caspase-inde-
pendent necrotic pathway, we first screened various com-
pounds for the ability to inhibit the FKBP-FADD–
induced death of JB6 cells. We found that PDTC inhibits
the process in a dose-dependent manner. As shown in Fig.
2 A, AP1510 treatment killed 90% of the cells within 4 h.
However, when the cells were preincubated with 80 
 
m
 
M
PDTC, 90% of the cells survived for at least 4 h. A similar
inhibitory effect of PDTC was observed with JB6 cells ex-
pressing FKBP-DED. That is, death was substantially de-
layed by pretreating the cells with PDTC (Fig. 2 B). PDTC
is known to work as an antioxidant (Liu et al., 1996). How-
ever, other antioxidants, such as butylated hydroxyanisole
(BHA, 250 
 
m
 
M) and nordihydroguaiaretic acid (25 
 
m
 
M),
showed little inhibitory effect on the FADD-induced
death of JB6 cells (data not shown).
 
Changes of Mitochondrial Membrane Potential and 
Release of Cytochrome c in Caspase-independent
Cell Death
 
The death of JB6 cells induced by the oligomerization of
FADD is accompanied by massive swelling of the mito-
Figure 1. Requirement for the DED in FADD-mediated and
caspase-independent cell death. (A) Structure of chimeric mole-
cules of FKBP with FADD and its derivatives. FKBP represents
the region of amino acids 2–108 of human FK506–binding pro-
tein. FADD-DD, FADD-DED, and FADD-DDED contain
amino acids 105–208, 1–117, and 79–117 of human FADD, re-
spectively. Myr and FLAG indicate the myristilation-targeting
peptide and FLAG epitope, respectively. (B) Death of Jurkat and
JB6 cells by oligomerization of FADD-DED. Jurkat (open sym-
bols) and JB6 (closed symbols) cells were transformed with the
expression plasmid for FADD (circles), FADD-DD (squares),
FADD-DED (triangles), or FADD-DDED (diamonds). The sta-
ble transformant clones were incubated at 378C for 6 h with the
indicated concentrations of AP1510, and the cell viability was de-
termined by the WST-1 method. The results are expressed as a
percent of the value obtained without AP1510. The experiments
were performed in triplicate, and the average values were plotted. 
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chondria (Kawahara et al., 1998). To examine whether mi-
tochondria are functional in JB6 cells that are dying due to
the oligomerization of DED, the 
 
DC
 
m was measured by
staining with the Mitotracker reagent. As shown in Fig. 3
A, 
 
DC
 
m dramatically decreased within 3 h after the addi-
tion of AP1510. This reduction in 
 
DC
 
m was greatly inhib-
ited by preincubation of the cells with 80 
 
m
 
M PDTC,
which is consistent with the inhibitory effect of PDTC on
cell death. The TNF-induced necrotic cell death of mouse
L929 cells is accompanied by formation of oxygen radicals
(Vercammen et al., 1998a). To examine whether oxygen
radicals are involved in the loss of 
 
DC
 
m of FADD-DED–
induced death of JB6 cells, the cells were stained with a re-
duced version of the Mitotracker reagent (CM-H
 
2
 
TMRos)
that emits fluorescence only after oxidation. As shown in
Fig. 3 B, the staining intensity with this reagent did not in-
crease after the treatment with AP1510. This was not due
to the inability of the reagent to enter mitochondria, be-
cause the treatment of the cells with 
 
t
 
-butyl hydroperoxide
Figure 2. Inhibitory effect of PDTC on the cell death induced by
FADD oligomerization. (A) Dose-dependent effect of PDTC.
JB6 cell transformants expressing FKBP-FADD were pretreated
at 378C for 1 h with the indicated concentrations of PDTC. The
cells were divided into two samples, and each was incubated at
378C for 4 h, with or without 0.5 mM AP1510. The WST-1 assay
was carried out as described in Materials and Methods, and the
cell viability of the PDTC-treated cells is expressed as the percent
of the value obtained without AP1510. The experiments were
performed in triplicate, and the average values were plotted with
SD (bars). (B) Time-dependent cell death by FADD oligomeriza-
tion. Two JB6 transformant clones (circles and triangles) express-
ing FKBP-DED were preincubated at 378C for 1 h, with (open
symbols) or without (closed symbols) 80 mM PDTC. The cells
were then incubated for the indicated time periods with 0.5 mM
AP1510, and the cell viability was determined as described above.
Figure 3. Changes of mitochondrial functions in the FADD-
DED–induced death of JB6 cells. (A) Reduction of DCm by
FADD oligomerization. JB6 cell transformants expressing
FKBP-DED were preincubated for 1 h, with (green areas) or
without (red lines) 80 mM PDTC, and then were incubated at
378C, for the indicated time periods, with 0.5 mM AP1510. The
DCm was determined by the Mitotracker orange reagent CMT-
MRos, as described in Materials and Methods. The FACS® pro-
files of the cells without treatment with AP1510 are shown in
open areas with dotted lines. (B) No oxygen radical formation in
mitochondria by FADD oligomerization. JB6 cell transformants
expressing FKBP-DED were incubated at 378C for 1 h with 0.5
mM AP1510, 0.73 mM t-butyl hydroperoxide, or both. The cells
were then stained with the Mitotracker orange reagent CM-
H2TMRos, and the FACS® profiles are shown by the green areas.
The open areas show the FACS® profiles for the proliferating
cells. (C) No release of cytochrome c from mitochondria during
FADD-DED–induced death of JB6 cells. A JB6 transformant
clone expressing FKBP-DED was incubated at 378C for the indi-
cated time periods with 0.5 mM AP1510. The cells were homoge-
nized with a Dounce homogenizer, and the cell extracts were
fractionated into heavy membrane and soluble fractions by cen-
trifugation, as described in Materials and Methods. Proteins (5
mg) of the heavy membrane and S100 fraction were separated by
SDS-PAGE, blotted onto a PVDF membrane, and probed with
monoclonal antibodies against cytochrome c, cytochrome oxi-
dase subunit II (COXII), and human caspase 3. Sizes of molecu-
lar weight standard proteins are shown in kilodaltons to the left. 
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significantly increased the fluorescence in the presence or
absence of AP1510.
Various apoptotic stimuli cause the release of cyto-
chrome c from mitochondria (Kluck et al., 1997; Yang et
al., 1997), and this release had been proposed to be due to
the loss of 
 
DC
 
m (Susin et al., 1997). Therefore, we exam-
ined whether cytochrome c was released from mitochon-
dria during the DED-induced death of JB6 cells. The JB6
cells expressing FKBP-DED were treated with AP1510
for various lengths of time and homogenized with a
Dounce homogenizer. After removing the unlysed cells,
the cell extracts were fractionated into heavy membrane
(precipitates of 10,000 
 
g
 
) and cytosolic (supernatant of
100,000 
 
g
 
) fractions, and then they were analyzed by West-
ern blotting with anti–cytochrome c antibodies. As shown
in Fig. 3 C, no cytochrome c was detected in the S100 frac-
tion, even 4 h after the addition of AP1510. Rather, the
apparent content of cytochrome c in the heavy membrane
fractions increased. The amount of cytochrome oxidase
subunit II in this fraction increased similarly in a time-
dependent manner. These results may indicate that the
relative proportion of mitochondria increased in the heavy
membrane fraction because the dying cells were more eas-
ily disrupted. Cytochrome c that is released into the cyto-
sol can process procaspase 3 into its mature form through
the activation of caspase 9 (Li et al., 1997). In agreement
with the observed lack of cytochrome c release from mito-
chondria, the procaspase 3 remained intact 4 h after the
addition of AP1510 (Fig. 3 C).
 
The Death Signals from the Fas Receptor in
Fas-overexpressing Cells
 
When the endogenously expressed Fas of Jurkat cells is en-
gaged by anti–human Fas antibodies, the cells die, and this
process can be blocked by caspase inhibitors. On the other
hand, the above results indicated that JB6 cells, a Jurkat-
derived cell line, can be killed in a caspase-independent
manner when FADD or its DED is tightly aggregated. To
examine whether the caspase-independent death signal can
be transduced from Fas, Jurkat cell transformants (JmF)
that overexpress mouse Fas were established. As shown in
Fig. 4, when the transformants were treated with the anti–
mouse Fas antibody (Jo2), the cells died. This cell death
process was quicker than that observed with JmF cells
treated with the anti–human Fas antibody, suggesting that
overexpression of mouse Fas and its engagement with the
anti–mouse Fas antibody can generate a stronger death sig-
nal than that elicited through endogenously expressed Fas.
Preincubation of JmF cells with 0.5 mM z-VAD–fmk, but
not with PDTC, significantly blocked the anti–mouse Fas-
induced death process (Fig. 4). However, PDTC in the
presence of z-VAD–fmk had an additional inhibitory effect
on the death process in a dose-dependent manner. Thus,
preincubation of the cells with 0.5 mM z-VAD–fmk and 80
 
m
 
M PDTC almost completely inhibited the Fas-induced
death of JmF cells. These results indicate that when the
caspases are functional, the caspase-dependent death path-
way dominates the caspase-independent pathway. How-
Figure 4. Inhibitory effects of a caspase inhibitor and PDTC on
the Fas-induced cell death. JmF cells were incubated with 1 mg/ml
Jo2 antibody alone (s) or in the presence of 40 mM PDTC (n),
80 mM PDTC (h), 0.5 mM z-VAD–fmk (d), 40 mM PDTC and
0.5 mM z-VAD–fmk (m), and 80 mM PDTC and 0.5 mM z-VAD–
fmk (j). After incubation at 378C for the indicated time periods,
cell viability was determined by the WST-1 assay, as described in
Materials and Methods. The results are expressed as the percent
of the value obtained without the Jo-2 antibody. The experiments
were performed in triplicate, and the average values were plotted.
Figure 5. Inhibitory effects of PDTC and z-VAD–
fmk on Fas-induced reduction of the DCm. JmF
cells (106 cells/ml) were incubated at 378C with 1 mg/
ml Jo2 antibody alone (first column) or in the pres-
ence of 80 mM PDTC (second column), 0.5 mM
z-VAD–fmk (third column), or 80 mM PDTC and
0.5 mM z-VAD–fmk (fourth column). After incuba-
tion for the indicated time periods (shown to the left
of each row), DCm was measured, as described in
Materials and Methods. The FACS® profiles are
shown in the green areas. The FACS® profiles of
cells without anti-Fas antibody treatment are indi-
cated by open areas with dotted lines in all panels,
whereas those obtained without inhibitors are indi-
cated by open areas with red lines in the panels of
the second, third, and fourth columns. 
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ever, even when the caspases are not functional, cells die by
Fas activation via a caspase-independent mechanism.
The change in 
 
DC
 
m in the Fas-activated cells was then
measured in the absence or presence of z-VAD–fmk and
PDTC. As shown in Fig. 5, Fas activation caused a gradual
reduction in the 
 
DC
 
m of JmF cells. PDTC had little effect
on the kinetics of the 
 
DC
 
m loss. Preincubation of the cells
with z-VAD–fmk blocked the loss of 
 
DC
 
m at an early stage
of cell death. That is, 
 
.
 
80% of the cells showed an intact
 
DC
 
m 6 h after Fas activation, which agrees with the sce-
nario that most cells were alive at this point (Fig. 4). How-
ever, at a later time point (9 h after the addition of anti-Fas
antibody), the 
 
DC
 
m of half the cell population was com-
pletely lost. This loss of 
 
DC
 
m was blocked by adding PDTC
together with z-VAD–fmk. These results suggest that the
gradual reduction in 
 
DC
 
m during the Fas-induced cell death
process is caspase dependent, whereas the Fas-induced
caspase-independent death signal causes a sharper reduc-
tion in 
 
DC
 
m that occurs later in the cell-death process.
We then examined the release of cytochrome c from mi-
tochondria during the Fas-activated death of JmF cells. As
shown in Fig. 6, cytochrome c was detected in the cytosolic
fraction within 1 h of Fas activation, which was accompa-
nied by the processing of procaspase 3. Pretreatment of
the cells with PDTC had no effect on the release of cyto-
chrome c, though it slightly delayed the processing of pro-
caspase 3. In contrast, z-VAD–fmk completely blocked
the release of cytochrome c, indicating that the release of
cytochrome c from mitochondria is a caspase-dependent
process. The amount of mitochondria in the heavy mem-
brane fractions was also enhanced under these conditions.
 
Apoptotic and Necrotic Morphological Changes in the 
Fas-activated JmF Cells
The above results suggested that Fas can transduce the
caspase-dependent as well as -independent cell death sig-
nals. To correlate of these cell death processes with apop-
tosis and necrosis, the Fas-activated dying cells were exam-
ined by transmission electron microscopy. As previously
reported with various Fas-expressing cells (Itoh et al.,
1991; Ni et al., 1994), the engagement of Fas by the agonis-
tic anti-Fas antibody in JmF cells caused condensation and
fragmentation of the nuclei, as well as shrinkage of the
cells (Fig. 7), which are characteristics of apoptosis. These
apoptotic morphological changes were not inhibited by
preincubation with PDTC. When the cells were stimulated
with the anti-Fas antibody in the presence of z-VAD–fmk,
the cells looked morphologically normal for up to 6 h (data
not shown). However, at 9 h after the Fas activation, their
cytoplasm looked electron translucent and their mitochon-
dria showed a high degree of swelling, characteristics that
accompany necrotic cell death. The addition of PDTC to-
gether with z-VAD–fmk blocked the bleaching of the cyto-
plasm and the swelling of the mitochondria, though many
vacuole-like structures were observed in the cells.
Figure 6. Selective inhibition of the Fas-induced apoptotic
pathway by a caspase inhibitor. JmF cells were incubated with 1
mg/ml Jo2 antibody at 378C for the indicated time periods in the
absence (2) or presence (1) of 0.5 mM z-VAD–fmk or 80 mM
PDTC. Cells were homogenized with a Dounce homogenizer,
and the heavy membrane and S100 fractions were prepared by
centrifugation. Proteins (5 mg) of the heavy membrane and
S100 fractions were separated by SDS-PAGE and subjected to
Western Blotting using monoclonal antibodies against cyto-
chrome c, cytochrome oxidase subunit II (COXII), and caspase
3. Sizes of molecular weight standards are shown in kilodaltons
to the left.
Figure 7. Apoptotic and necrotic cell
death through the Fas receptor. JmF cells
were preincubated at 378C for 1 h with 80
mM PDTC (C), 0.5 mM z-VAD–fmk (D),
or 80 mM PDTC plus 0.5 mM z-VAD–fmk
(E). Then the cells were treated at 378C
for 12 h with 1 mg/ml Jo2 antibody and ex-
amined by electron transmission micros-
copy using a Hitachi H7100. As controls,
cells were left untreated (A) or treated
with Jo2 antibody without preincubation
with inhibitors (B). Bars, 1 mm.Matsumura et al. Fas-mediated Necrotic Cell Death 1253
The FasL–Induced Death Signals in Human
Jurkat Cells
The above results indicated that the activation of Fas can
activate both apoptotic and necrotic signals, at least in Fas-
overexpressing Jurkat cells. Under physiological condi-
tions, FasL binds to the Fas receptor and activates the
death signals. FasL is a type II membrane protein, and the
cell-associated FasL has a stronger cytotoxic activity than
its soluble form (Tanaka et al., 1998). Recently, Walczak
et al. (1999) prepared the soluble form of FasL, which was
tagged with a leucine-zipper motif, and showed that it has
a strong cytotoxic activity. In fact, wild-type Jurkat cells
were efficiently killed by the treatment with LZ-FasL. As
shown in Fig. 8 A, LZ-FasL, at 50 ng/ml, killed most of
Jurkat cells within 6 h, which is much faster than that
observed with anti–human Fas monoclonal antibody (CH-
11) (Kawahara et al., 1998). Although this cell death pro-
cess was inhibited by the addition of 25 mM of z-VAD–
fmk at its earlier stage (6 h), cells still died when they were
incubated for .9 h (Fig. 8 A). This cell death was blocked
by adding PDTC, suggesting that FasL can activate
caspase-dependent and -independent cell deaths. We then
examined whether JB-6 cells were sensitive to LZ-FasL–
induced cell death. As shown in Fig. 8 B, JB-6 cells lacking
caspase 8 were killed within 12 h in a dose-dependent
manner. The concentration of LZ-FasL required to give a
half-maximal killing was slightly higher than that required
to kill Jurkat cells in the presence of z-VAD (Fig. 8 B), but
a similar concentration of the supernatant of COS cell,
which were transfected with the empty vector, had no ef-
fect (data not shown). These results indicate that FasL, the
physiological ligand for Fas, can activate caspase-depen-
dent and -independent cell death.
Discussion
Apoptosis and necrosis have traditionally been regarded
as two different death processes induced by different stim-
uli (Wyllie et al., 1980; Duval and Wyllie, 1986). However,
recent studies indicate that some stimuli, such as TNF, can
induce either apoptosis or necrosis, depending on the cell
type (Vercammen et al., 1998a; Fiers et al., 1999). Geno-
toxic agents that cause apoptosis also cause necrosis in
several cell lines when the apoptotic process is inhibited by
caspase inhibitors (Lemaire et al., 1998). We showed here
that Fas can transduce caspase-dependent apoptotic and
caspase-independent necrotic death signals. Both signals
were mediated through the DED of FADD. In JmF cells,
the apoptotic pathway dominated the necrotic pathway at
the early stage and was accompanied by the release of cy-
tochrome c from mitochondria and the processing of pro-
caspase 3. According to Scaffidi et al. (1998), human Jur-
kat cells are the type II cells in which caspase 8 that is
activated by Fas engagement cleaves Bid and causes cyto-
chrome c release from the mitochondria (Krammer, 1999).
The apoptotic pathway, including the cytochrome c re-
lease in JmF cells, was inhibited by a broad caspase inhibi-
tor, z-VAD–fmk, a result that agrees with the model for
type II cells. The loss of mitochondrial membrane poten-
tial (DCm) is observed in the apoptosis induced by a vari-
ety of stimuli (Shimizu et al., 1996; Zamzami et al., 1996)
and has been proposed to be essential for the release of cy-
tochrome c and/or apoptosis-inducing factor from mito-
chondria (Susin et al., 1997). However, even when DCm
was substantially lost during the necrosis of JmF cells, no
release of cytochrome c was observed (Fig. 6), suggesting
that the loss of DCm is not sufficient to release cyto-
chrome c from mitochondria. A similar conclusion was re-
ported by Bossy-Wetzel et al. (1998) for the staurosporine-
induced cell death. A slight and gradual loss of DCm
during the Fas-induced apoptosis of JmF cells may be a
secondary effect caused by the release of cytochrome c.
In contrast to apoptosis, the necrotic pathway func-
tioned independent of the caspases. Even caspase 8–null
Figure 8. Effects of z-VAD–fmk and PDTC on the FasL-induced
cell death of Jurkat cells. (A) Effects of inhibitors on the cell
death. Jurkat cells were incubated with 50 ng/ml LZ-FasL alone
(s) or in the presence of 80 mM PDTC (n), 25 mM z-VAD–fmk
(h), or 80 mM PDTC plus 25 mM z-VAD–fmk (d). After incuba-
tion at 378C for the indicated time periods, cell viability was de-
termined by the WST-1 assay, as described in Materials and
Methods. The results are expressed as the percent of the value
obtained without LZ-FasL. The experiments were performed in
triplicate, and the average values were plotted. (B) A dose-
dependent killing of JB6 cells by LZ-FasL. Jurkat cells (black
bars) and JB6 cells (white bars) were incubated at 378C for 12 h
with the indicated concentration of LZ-FasL. The Jurkat cells
were treated with LZ-FasL in the absence (2) or presence of 25
mM z-VAD–fmk (1). The experiments were carried out in tripli-
cate, and the average values were shown with SD. Similar results
were obtained by two other independent experiments.The Journal of Cell Biology, Volume 151, 2000 1254
cells died when FADD was oligomerized. This process
was accompanied by a sudden loss of DCm. Such a loss of
DCm would reduce the cellular ATP level, which may
lead to necrotic cell death (Eguchi et al., 1997; Leist et al.,
1997). In mouse L929 cells, an excess of oxygen radicals is
produced upon activation with TNF and Fas (Vercammen
et al., 1998a, b). Since BHA, a radical scavenger, blocks
the TNF- and Fas-induced necrotic pathway in L929 cells,
it was postulated that oxygen radicals are responsible for
necrotic cell death. Although reactive oxygens would re-
duce the DCm, we could not detect a significant produc-
tion of reactive oxygen intermediates during the FADD-
DED–induced necrosis in JB6 cells, and BHA could not
inhibit the death process, suggesting that oxygen radicals
are not responsible for the loss of DCm in our Jurkat sys-
tem. In contrast, we found that PDTC efficiently inhibited
Fas- or FADD-DED–induced necrosis. How PDTC
blocks the process is not clear. PDTC is a thiol compound,
works as an antioxidant or prooxidant, and has cytotoxic
effects (Orrenius et al., 1996). It inhibits the induction of
some transcription factors such as NF-kB, whereas it acti-
vates other transcription factors such as AP-1, p53, and
NF-AT. Although the JNK-AP1 pathway has been sug-
gested for Fas-mediated cell death, we found no signifi-
cant activation of JNK in FADD-induced necrotic cell
death (Shimizu, Y., H. Matsumura, A. Kawahara, and S.
Nagata, unpublished observations). Moreover, inhibitors
of protein synthesis or RNA synthesis (cycloheximide or
actinomycin D) did not inhibit the FADD-DED–medi-
ated necrosis (data not shown), indicating that, as for
Fas-mediated apoptosis, all components necessary for
necrotic cell death are present in proliferating cells. It
is likely that a DED-containing molecule(s) binds to
FADD-DED and is activated by oligomerization. In any
case, this signaling pathway should lead to the loss of
DCm and should be inhibited by PDTC. Identification of
molecules involved in necrotic signal transduction and the
development of its specific inhibitor will be necessary to
address whether or not the inhibition of loss of DCm
blocks eventual cell death.
Our present results indicate that Fas can activate two
distinct death pathways that branch at FADD. Since em-
bryonal fibroblasts from caspase 8–null mice or caspase
8–deficient Jurkat cells are resistant to the Fas-activated
death (Kawahara et al., 1998; Varfolomeev et al., 1998),
we think that the engagement of Fas usually causes apop-
tosis. However, when Fas is strongly activated for long
periods of time without phagocytosis of the apoptotic
cells, the cells may undergo necrotic cell death. In this re-
gard, it is noteworthy that the administration of FasL or
agonistic anti-Fas antibodies to animals brings about
massive hemorrhagic necrosis in the liver (Ogasawara et
al., 1993; Walczak et al., 1999), suggesting that Fas can
transduce necrotic death signal under some pathological
conditions. Recently, Lauzurica et al. (1999) showed that
TNF-a–induced septic shock in vivo can be blocked by
pretreating mice with PDTC, suggesting that TNFa can
also transduce the PDTC-inhibited death signal. The
demonstration that FADD-DED is responsible for the
necrotic death signal in caspase 8–null cells will assist fur-
ther studies targeted at identifying other molecules in-
volved in necrotic cell death.
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